Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease

Optimizing the speed of intravenous immunoglobulin infusion for Kawasaki Disease

Saved in:

Bibliographic Details
Main Author:	Chia-Yi Chin, MD, MS
Format:	Article
Language:	English
Published:	Elsevier 2024-09-01
Series:	Pediatrics and Neonatology
Online Access:	http://www.sciencedirect.com/science/article/pii/S187595722400130X
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The efficacy and safety of intravenous immunoglobulin infusion in 12 h for the initial treatment of Kawasaki disease
by: Satoshi Asano, et al.
Published: (2024-09-01)

Sonographic Gallbladder Abnormality Is Associated with Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Chih-Jen Chen, et al.
Published: (2012-01-01)

Treatment of a patient with Kawasaki disease associated with selective IgA deficiency by continuous infusion of cyclosporine A without intravenous immunoglobulin
by: Tatsuya Anzai, et al.
Published: (2016-12-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model
by: Gahao Chen, et al.
Published: (2025-01-01)

Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study
by: Satoki Hatano, et al.
Published: (2025-05-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

A machine learning-based model to predict intravenous immunoglobulin resistance in Kawasaki disease
by: Yuhan Xia, et al.
Published: (2025-03-01)

Clinical prediction of intravenous immunoglobulin-resistant Kawasaki disease based on interpretable Transformer model.
by: Gahao Chen, et al.
Published: (2025-01-01)

FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
by: Ho-Chang Kuo, et al.
Published: (2015-01-01)

Interpretable web-based machine learning model for predicting intravenous immunoglobulin resistance in Kawasaki disease
by: Ying He, et al.
Published: (2025-06-01)

Risk factors of intravenous immunoglobulin resistance and coronary arterial lesions in Turkish children with Kawasaki disease
by: Serkan Türkuçar, et al.
Published: (2020-02-01)

EXPERIENCE OF INTRAVENOUS INJECTION OF NORMAL HUMAN IMMUNOGLOBULIN IN A PATIENT WITH KAWASAKI SYNDROME
by: T. V. Sleptsova, et al.
Published: (2014-07-01)

A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
by: Wei Li, et al.
Published: (2021-01-01)

Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience
by: Yan Wang, et al.
Published: (2023-01-01)

The effects of glucocorticoid plus intravenous immunoglobulin (IVIG) vs IVIG alone on platelet activation in children with Kawasaki disease
by: Qiong-Qiong Wang, et al.
Published: (2023-08-01)

Impact of intravenous immunoglobulin treatment on peripheral blood cells in children with Kawasaki disease complicated with coronary artery lesion
by: Junshan Zhao, et al.
Published: (2025-02-01)

A visualized nomogram to predict intravenous immunoglobulin resistance in Kawasaki disease: a study based on the population in Southern China
by: Xinping Lin, et al.
Published: (2025-04-01)

Association between C-reactive protein–albumin–lymphocyte (CALLY) index with intravenous immunoglobulin non-response in Kawasaki disease
by: Yan Duan, et al.
Published: (2025-12-01)

Establishment and validation of risk prediction model to predict intravenous immunoglobulin-resistance in Kawasaki disease based on meta-analysis of 15 cohorts
by: Shuhui Wang, et al.
Published: (2025-02-01)

Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?-Current evidence based on a meta-analysis.
by: Xiaolan Zheng, et al.
Published: (2021-01-01)

Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion
by: Meir Mizrahi, et al.
Published: (2009-01-01)

High Efficiency of Human Normal Immunoglobulin for Intravenous Administration in a Patient with Kawasaki Syndrome Diagnosed in the Later Stages
by: Tatyana V. Sleptsova, et al.
Published: (2016-09-01)

The place of intravenous immunoglobulin in rheumatic diseases
by: N. V. Seredavkina, et al.
Published: (2016-01-01)

Peculiar features of intravenous immunoglobulins application in rheumatic diseases
by: O. N. Egorova, et al.
Published: (2024-06-01)

Intravenous immunoglobulin: prospects in patients with autoimmune rheumatic diseases
by: Elena Aleksandrovna Aseeva, et al.
Published: (2014-03-01)

A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.
by: Seiichiro Takeshita, et al.
Published: (2017-01-01)

INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRIC RHEUMATOLOGY PRACTICE
by: E. I. Alexeeva, et al.
Published: (2015-04-01)

Use of Intravenous Immunoglobulins in Intensive Therapy
by: E. A. Latysheva, et al.
Published: (2012-06-01)

INTRAVENOUS IMMUNOGLOBULIN APPLICATION IN CLINICAL PRACTICE
by: T. V. Latysheva, et al.
Published: (2013-01-01)

Use of intravenous immunoglobulin in neonates with haemolytic disease and immune thrombocytopenia
by: Marković-Sovtić Gordana, et al.
Published: (2013-01-01)

Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases
by: Zhi Guo, et al.
Published: (2025-04-01)

Therapeutic efficacy of intravenous immunoglobulin in ulcerative colitis
by: LONG Qian, et al.
Published: (2025-04-01)

SPECIFIC IMMUNOGLOBULINS FOR INTRAVENOUS INJECTION IN PEDIATRIC PRACTICES
by: A.L. Zaplatnikov
Published: (2007-02-01)

The clinical value of dynamic monitoring of complete blood count in predicting immunoglobulin resistance in Chinese children with Kawasaki disease
by: Xiaoqian Fang
Published: (2025-05-01)

Impact of 10% vs. 5% immunoglobulin products on treatment outcomes in Kawasaki disease: a multicenter retrospective study
by: Daichi Sajiki, et al.
Published: (2025-05-01)

Troubled with bloody intravenous infusion set?: Pressure infusion bag comes to rescue
by: Amit Kumar, et al.
Published: (2024-12-01)

Assistance algorithm of nursing for amiodarone intravenous infusion
by: Francimar Tinoco de Oliveira, et al.
Published: (2014-10-01)

Assistance algorithm of nursing for amiodarone intravenous infusion
by: Francimar Tinoco de Oliveira, et al.
Published: (2014-10-01)

Effects of intravenous immunoglobulin on clinical and immunological findings of patients with humoral immunodeficiency diseases
by: F Ersoy, et al.
Published: (1992-10-01)

Successful treatment of recalcitrant amyopathic dermatomyositis with deucravacitinib in addition to intravenous immunoglobulin
by: Megan E. McNamara, PhD, et al.
Published: (2025-08-01)